|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer 10/09/01 Swink James D Jr SC 13D/A 1:15K Nuo Therapeutics, Inc Bart Barnwell BDR Consulting, Inc. (Jim D. Swink, Jr.) Charles Worden David Alexander David Crews Dennis Hendren Lewis Pollack Richard O’Brien Robert Burkett Robert McHenry Sidney Dabbs |
Document/Exhibit Description Pages Size
1: SC 13D/A Amendment to General Statement of Beneficial HTML 30K
Ownership
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D/A
(Rule 13d-101)
Under the Securities Exchange Act of 1934
(Amendment No. 1 )*
CYTOMEDIX, INC.
(Name of Issuer)
COMMON STOCK
(Title of Class of Securities)
(CUSIP Number)
D. NICOLE LOVELL, ESQ.
WILLIAMS & ANDERSON LLP
111 CENTER STREET, 22ND FLOOR
(501) 372-0800
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications)
(Date of Event Which Requires Filing of This Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. [ ]
Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule 13d-7 for other parties to whom copies are to be sent.
[FN*] The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
CUSIP No. 23283B 10 5
----------------------------------------------------------------------------------------------------------------------
(1) Names of reporting persons
I.R.S. Identification Nos. of above persons (entities only)
BDR CONSULTING, INC. (JIM D. SWINK, JR.)
IRS IDENTIFICATION NO. 62-1703402
----------------------------------------------------------------------------------------------------------------------
(2) Check the appropriate box if a member of a group
(a) [X]
(b) [ ]
----------------------------------------------------------------------------------------------------------------------
(3) SEC use only
----------------------------------------------------------------------------------------------------------------------
(4) Source of funds (see instructions)
WC AND PF
----------------------------------------------------------------------------------------------------------------------
(5) Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)
[ ]
----------------------------------------------------------------------------------------------------------------------
(6) Citizenship or place of organization
DAVID ALEXANDER - ARKANSAS
BART BARNWELL - ARKANSAS
ROBERT BURKETT - NEW YORK
DAVID CREWS - ARKANSAS
SIDNEY DABBS - ARKANSAS
DENNIS HENDREN - ARKANSAS
ROBERT MCHENRY - ARKANSAS
RICHARD O'BRIEN - ARKANSAS
LEWIS POLLACK - FLORIDA
CHARLES WORDEN - ARKANSAS
BDR CONSULTING, INC. - ARKANSAS
----------------------------------------------------------------------------------------------------------------------
Number of shares beneficially owned by each reporting person with:
(7) Sole voting power
DAVID ALEXANDER - 12,625
BART BARNWELL - 89,680
ROBERT BURKETT - 121,918
DAVID CREWS - 147,394
SIDNEY DABBS - 325,115
DENNIS HENDREN - 396,001
ROBERT MCHENRY - 0
RICHARD O'BRIEN - 6,468
LEWIS POLLACK - 123,466
CHARLES WORDEN - 388,100
BDR CONSULTING, INC. - 851,565
----------------------------------------------------------------------------------------------------------------------
(8) Shared voting power
DAVID ALEXANDER - 72,655
ROBERT MCHENRY - 60,958
RICHARD O'BRIEN - 54,490
LEWIS POLLACK - 1,452
----------------------------------------------------------------------------------------------------------------------
(9) Sole dispositive power
DAVID ALEXANDER - 12,625
BART BARNWELL - 89,680
ROBERT BURKETT - 121,918
DAVID CREWS - 147,394
SIDNEY DABBS - 325,115
DENNIS HENDREN - 396,001
ROBERT MCHENRY - 0
RICHARD O'BRIEN - 6,468
LEWIS POLLACK - 123,466
CHARLES WORDEN - 388,100
BDR CONSULTING, INC. - 851,565
----------------------------------------------------------------------------------------------------------------------
(10) Shared dispositive power
DAVID ALEXANDER - 72,655
ROBERT MCHENRY - 60,958
RICHARED O'BRIEN - 54,490
LEWIS POLLACK - 1,452
----------------------------------------------------------------------------------------------------------------------
(11) Aggregate Amount Beneficially Owned by Each Reporting Person
DAVID ALEXANDER - 85,280
BART BARNWELL - 89,680
ROBERT BURKETT - 121,918
DAVID CREWS -147,394
SIDNEY DABBS - 325,115
DENNIS HENDREN - 396,001
ROBERT MCHENRY - 60,958
RICHARD O'BRIEN - 60,958
LEWIS POLLACK - 124,918
CHARLES WORDEN - 388,100
BDR CONSULTING, INC. - 851,565
----------------------------------------------------------------------------------------------------------------------
(12) Check if the aggregate amount in Row (11) excludes certain shares
(see instructions).
[ ]
----------------------------------------------------------------------------------------------------------------------
(13) Percent of class represented by amount in Row (11)
21.0%
----------------------------------------------------------------------------------------------------------------------
(14) Type of reporting person
BDR CONSULTING, INC. - CO
ALL OTHERS - IN
----------------------------------------------------------------------------------------------------------------------
SCHEDULE 13D/A
This Schedule 13D/A amends the prior Schedule 13D filed on behalf of this group on October 9,
2001.
ITEM 1. SECURITY AND ISSUER
Common Stock of Cytomedix, Inc.
Three Parkway North, Deerfield, Illinois 60015
ITEM 2. IDENTITY AND BACKGROUND
(a)(b) and (c)
David Alexander is a vice president of Crews and Associates, a brokerage house, located at 2000 Union National Plaza, 124 West Capital, Little Rock, Arkansas 72201.
Bart Barnwell is a vice president of Crews and Associates, a brokerage house, located at 2000 Union National Plaza, 124 West Capital, Little Rock, Arkansas 72201.
Robert Burkett is a consultant with the Carmen Group, a consulting firm, and works out of his home at 19 Rock Hill Lane, Scarsdale, New York, 10583.
David Crews is an executive vice president of Crews and Associates, a brokerage house, located at 2000 Union National Plaza, 124 West Capital, Little Rock, Arkansas 72201.
Sidney Dabbs, of 8 Thomas Park Circle, Little Rock, Arkansas 72223, is retired.
Dennis Hendren is a manager at Belumedix, LLC, a veterinarian pharmaceutical company, located at 11524 N. Rodney Parham Road in Little Rock, Arkansas 72212.
Robert McHenry is an attorney at McHenry law firm located at 8210 Henderson Road, Little Rock, Arkansas 72210.
Richard O'Brien is a vice president of Crews and Associates, a brokerage house, located at 2000 Union National Plaza, 124 West Capital, Little Rock, Arkansas 72201.
Lewis Pollack is the C.M.O at Qtelecom Corporation, a telecommunications company, 2384 N.W. 49th Lane, Boca Raton, Florida 33431.
Charles Worden is a research director at Belumedix, LLC, a veterinarian pharmaceutical company, located at 11524 N. Rodney Parham Road in Little Rock, Arkansas 72212.
BDR Consulting, Inc. (president - Jim D. Swink, Jr.) of 10 Levant, Little Rock, Arkansas 72212, is a consulting corporation incorporated in Arkansas.
(d) and (e). During the five years prior to the date hereof, no member of this group (i) has been convicted in a criminal proceeding (excluding traffic offenses and other similar misdemeanors) and (ii) has been a party to a civil proceeding where as a result of such proceeding, he was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.
(f). Alexander, Barnwell, Crews, Dabbs, Hendren, McHenry, O'Brien, Swink and Worden are all
citizens of the state of Arkansas. Burkett is a citizen of the state of New York, and Pollack is a
citizen of the state of Florida.
ITEM 3. SOURCE AND AMOUNT OF FUNDS OR OTHER CONSIDERATION
This stock was acquired by each member of the group by using personal funds or working
capital.
ITEM 4. PURPOSE OF TRANSACTION
(j). The group of shareholders organized for the purpose of holding their shares in order to be
recognized as "Debtor" under Bankruptcy Rule 9001(5) on behalf of Cytomedix, Inc. in the
bankruptcy court action designated Case No. B 27610 in the United States Bankruptcy Court for
the Northern District of Illinois, Eastern Division.
ITEM 5. INTEREST IN SECURITIES OF THE ISSUER
(a). According to the corporation's records as of September 20, 2001, the number of aggregate outstanding common shares is 12,610,557. The group's shares combined total 2,651,887, which is 21.0 % of the aggregate. Number eleven on the cover page is incorporated by reference.
(b). Each reporting person listed in number eleven on the cover page has the sole right to vote and/or dispose of his shares; however, four of the reporting persons hold (some or all of) his shares with his spouse. The person named in this report is the person who routinely votes those shares on behalf of himself and his spouse. The four reporting persons sharing the right to vote and/or dispose of their shares are David Alexander, Robert McHenry, Richard O'Brien, and Lewis Pollack. Numbers seven through ten on the cover page are incorporated by reference.
(c). Dennis Hendren bought 556 shares of common stock on August 24, 2001. Sidney Pollack
sold 2400 shares on August 8, 2001.
ITEM 6. CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER.
This group of shareholders orally agreed to hold and vote their shares together and to solicit
support in order to be named the "Debtor" under Bankruptcy Rule 9001(5) on behalf of
Cytomedix, Inc.
ITEM 7. MATERIAL TO BE FILED AS EXHIBITS
Not applicable.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
---------------------------------------------------------
---------------------------------------------------------
---------------------------------------------------------
/s/David Crews
---------------------------------------------------------
/s/Sidney Dabbs
---------------------------------------------------------
---------------------------------------------------------
---------------------------------------------------------
---------------------------------------------------------
---------------------------------------------------------
----------------------------------------------------------
BDR Consulting, Inc.
By: /s/Jim D. Swink, Jr.
----------------------------------------------------------
Jim D. Swink, Jr., President
---------------------------------------------------------
| This ‘SC 13D/A’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 10/9/01 | SC 13D | ||
| 9/21/01 | ||||
| 9/20/01 | ||||
| 8/24/01 | ||||
| 8/8/01 | 8-K | |||
| List all Filings | ||||